Search alternatives:
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
largest decrease » largest decreases (Expand Search), marked decrease (Expand Search)
linear decrease » linear increase (Expand Search)
larger decrease » marked decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a largest » _ largest (Expand Search), a large (Expand Search), a latest (Expand Search)
-
18761
-
18762
-
18763
<i>Oenocarpus bacaba</i> palm tree (A) and fruit (B).
Published 2024“…Its spread to non-endemic areas has made it a global health issue. The aim of this work is to demonstrate the difficulties encountered in handling a real-life situation.…”
-
18764
-
18765
-
18766
-
18767
-
18768
Iron and Steel Industry Emissions: A Global Analysis of Trends and Drivers
Published 2023“…Conversely, NO<sub><i>x</i></sub> and SO<sub>2</sub> began declining recently due to stringent controls in major contributors such as China, a trend expected to persist. Currently, end-of-pipe abatement technologies are key to PM<sub>2.5</sub> reduction, whereas process modifications are central to CO<sub>2</sub> mitigation. …”
-
18769
-
18770
-
18771
-
18772
-
18773
An idealized view of the opportunity provided by a comparative and integrated oncology drug development path.
Published 2013“…Data for transition rates and costs of Phase I, II, and III trials are based on published cost estimates <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000161#pmed.1000161-DiMasi2" target="_blank">[3]</a> and reported clinical phase transition probabilities for investigational oncology compounds from the 20 largest firms (by pharmaceutical sales in 2005) from 1993 to 2002 <a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000161#pmed.1000161-DiMasi1" target="_blank">[2]</a>,<a href="http://www.plosmedicine.org/article/info:doi/10.1371/journal.pmed.1000161#pmed.1000161-Roberts1" target="_blank">[4]</a>. …”
-
18774
-
18775
-
18776
-
18777
-
18778
-
18779
-
18780